Flu and Pneumonia Shots Safe for People with MS

Credibility

Interest

Share:2 min read

Key Takeaway

Getting a flu or pneumococcal (pneumonia) vaccine did not raise the risk of serious flare-ups in people with MS or other immune inflammatory diseases and may even be linked to a slightly lower risk.

What They Found

Researchers looked at health records for hundreds of thousands of people with immune-mediated inflammatory diseases, including over 9,000 people with MS for pneumococcal vaccine checks and over 30,000 for flu vaccine checks. They compared those who got vaccinated to similar people who did not, and then tracked emergency hospital visits for disease worsening. For MS patients, there was no sign of higher risk after pneumococcal or flu shots; the numbers were very close to no change and leaned slightly toward lower risk. Similar results were seen for inflammatory joint diseases and inflammatory bowel disease, with some groups showing a clearer small decrease in risk. Overall, the study found no evidence that these vaccines cause severe disease flare-ups that need emergency care, supporting their safety for these patients.

Who Should Care and Why

People with MS and their caregivers should care because vaccines are a common worry, and this study suggests flu and pneumonia shots don’t trigger severe relapses that need hospital care. Think of it like a safety check: getting the vaccine is not linked to bigger problems and may even help a little, similar to how wearing a seatbelt lowers risk rather than increases it. Healthcare providers who treat MS can use this information to reassure patients who are nervous about vaccinations. Caregivers can feel more confident encouraging routine vaccines, which protect against infections that can themselves make MS symptoms worse. Patients who are deciding about these vaccines can discuss timing and any individual concerns with their care team, but the overall message is that these vaccines are safe for most people with MS.

Important Considerations

This study used insurance records and looked at emergency hospital visits, so it may miss milder flares that did not lead to emergency care. The data come from one country and one insurance system, so results might be a bit different in other places or with different patient groups. Also, the study shows association (no increase in risk) but cannot prove vaccines cause benefits beyond protecting against the infections themselves.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Treatment Updates MS Diagnostics Specific Symptoms

Article Topics:

Worsening of diseaseinflammatory bowel diseasesinflammatory rheumatic and musculoskeletal diseasesinfluenza vaccinemultiple sclerosispneumococcal vaccine

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News